Micro-porous Paclitaxel-Loaded PLGA Foams -- a New Implant Material for Controlled Release of Chemotherapeutic Agents
Name
CPE004.pdf
Size
496.63 KB
Format
Adobe PDF
Checksum (MD5)
66882a5243de77d9b9139401eb973676
Author(s)
Lee, Lai Yeng
Wang, Chi Hwa
Smith, Kenneth A.
Date Issued
January 2007
Series/Report no.
Chemical and Pharmaceutical Engineering (CPE)
Abstract
Supercritical gas foaming using CO₂ was used to fabricate blank poly DL lactide-co-glycolide (PLGA) micro-porous foams. Paclitaxel-loaded PLGA foams were also produced for the first time using a modification of the supercritical gas foaming technique whereby pacltitaxel-loaded PLGA microparticle powders obtained from spray drying was foamed. In this study, it was found that using polymer powders, more compact foams and smaller pores foams may be achieved with lower saturation pressures and time which is due to the much higher surface area to volume ratio of the microparticle powders. Experiments were carried out with varying lactide to glycolide ratio of the copolymer PLGA and it was shown that the pore size, in vitro swelling behavior and drug release profiles may be altered by changing the copolymer composition used. The foams fabricated also have good mechanical strength which makes it suitable to be applied as an implantation material for the post-surgical controlled delivery of chemotherapeutic drugs. The residual organic solvent content of the paclitaxel-foams were well below the allowable limit set by the US Pharmacopeia as shown in the present study. The in vitro release profiles over a period of 5 weeks showed close to linear release.
Subjects
Supercritical Gas Foaming Technique
Poly DL Lactide-Co-Glycolide (PLGA)
Micro-porous Foams
Controlled Release
Paclitaxel
Persistent DSpace Link
